Abby Thompson’s Post

View profile for Abby Thompson, graphic

CEO @ DANA Brain Vital

The 2025 proposed CMS rule has some exciting news for #digitaltherapeutic devices. The proposed rule represents a significant advancement in expanding access to behavioral health services and DANA Brain Vital stands ready to play a pivotal role in this new era by providing objective outcome measurements on the efficacy of therapeutic interventions on cognitive function. Our advanced capabilities ensure that digital therapeutic companies can confidently demonstrate the impact of their products, thus meeting CMS requirements and optimizing patient care. DANA seamlessly integrates into existing application platforms, eliminating the need for it to be used as a separate application. This streamlined integration simplifies the process for digital therapeutic companies and enhances the overall user experience.  Moreover, DANA offers additional revenue opportunities for digital therapeutic clients by enabling them to leverage existing billing codes for therapeutic monitoring. https://lnkd.in/g2WT-22e

Calendar Year (CY) 2025 Medicare Physician Fee Schedule Proposed Rule

Calendar Year (CY) 2025 Medicare Physician Fee Schedule Proposed Rule

cms.gov

It's great to see advancements in expanding access to behavioral health services through the proposed CMS rule. Objective outcome measurements will undoubtedly play a crucial role in demonstrating the efficacy of therapeutic interventions. How do you envision digital therapeutic companies utilizing tools like DANA Brain Vital to meet CMS requirements and improve patient care?

Like
Reply
Peter Gilfillan

Helping People Explore Franchise Ownership | Be Own Boss | Follow Your Dreams | Create Wealth | Escape Corp America

4mo

Abby Thompson Exciting developments with the 2025 CMS rule! How do you see DANA Brain Vital transforming the landscape of behavioral health services?

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics